Last reviewed · How we verify

NCT06761443

To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults

Recruiting now NA Last updated 7 January 2025
What this trial tests

NA trial testing Probiotic in Constipation in 10 participants. Currently enrolling.

Timeline
25 February 2025
Primary endpoint
25 April 2025
25 May 2025

Quick facts

Lead sponsorWecare Probiotics Co., Ltd.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment10
Start date25 February 2025
Primary completion25 April 2025
Estimated completion25 May 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Wecare Probiotics Co., Ltd. — full company profile →

Who can join

Adults 18 to 70, any sex, with Constipation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the improvement of constipation symptoms, quality of life and mental state, intestinal function, intestinal hormones, inflammation and immunity, and intestinal flora of constipation subjects after 8-week intervention with Pediococcus acidilactici PA53.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Constipation

Currently open trials in the same condition.

Other Wecare Probiotics Co., Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing